Nektar Seeking New Partner For Exubera As Pfizer Returns Rights

Pfizer pays Nektar $135 million, resolving Exubera contract, and returns rights – providing Nektar finds a partner, firm tells “The Pink Sheet” DAILY.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet